Medite Cancer Diagnostics, Inc.

MDITOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$8672

P/E Ratio—

52W High$0.005

52W Low$0.0001

Avg Volume170.332

Open$0.00

Beta-37.15

Earnings Financials Revenue

Medite Cancer Diagnostics, Inc. (MDIT) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MDIT · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2018Report Date: Nov 14, 2018

EPS Actual

-$0.01

Revenue

—

Fiscal Period

Q4 FY2018

FY ends December

Report Date

Nov 14, 2018

After Market Close

MDIT reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q4 FY2018	Nov 14, 2018	—	-$0.01	—	—	—	—
— Q3 FY2018	Aug 10, 2018	—	-$0.01	—	—	—	—
— Q4 FY2017	Nov 14, 2017	—	-$0.06	—	—	—	—
— Q3 FY2017	Aug 14, 2017	—	-$0.06	—	—	—	—
— Q2 FY2017	May 15, 2017	—	-$0.04	—	—	—	—
— Q4 FY2016	Nov 15, 2016	—	-$0.02	—	—	—	—
— Q3 FY2016	Aug 25, 2016	—	-$0.01	—	—	—	—
— Q2 FY2016	Apr 12, 2016	—	-$0.03	—	—	—	—

Q4 FY2018

Nov 14, 2018

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2018

Aug 10, 2018

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2017

Nov 14, 2017

EPS Actual

-$0.06

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2017

Aug 14, 2017

EPS Actual

-$0.06

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2017

May 15, 2017

EPS Actual

-$0.04

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2016

Nov 15, 2016

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2016

Aug 25, 2016

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2016

Apr 12, 2016

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for MDIT.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q4 FY2018	Nov 14, 2018	—	$0.06	$0.06	+0.00%
— Q3 FY2018	Aug 10, 2018	—	$0.15	$0.15	+0.00%
— Q4 FY2017	Nov 14, 2017	—	$0.70	$0.70	+0.00%
— Q3 FY2017	Aug 14, 2017	—	$0.51	$0.51	+0.00%
— Q2 FY2017	May 15, 2017	—	$0.41	$0.41	+0.00%
— Q4 FY2016	Nov 15, 2016	—	$0.45	$0.45	+0.00%
— Q3 FY2016	Aug 25, 2016	—	$0.55	$0.55	+0.00%
— Q2 FY2016	Apr 12, 2016	—	$0.70	$0.70	+0.00%

Q4 FY2018+0.00%

Report Date

Nov 14, 2018

EPS Beat/Miss

—

Price Before

$0.06

Price After

$0.06

Q3 FY2018+0.00%

Report Date

Aug 10, 2018

EPS Beat/Miss

—

Price Before

$0.15

Price After

$0.15

Q4 FY2017+0.00%

Report Date

Nov 14, 2017

EPS Beat/Miss

—

Price Before

$0.70

Price After

$0.70

Q3 FY2017+0.00%

Report Date

Aug 14, 2017

EPS Beat/Miss

—

Price Before

$0.51

Price After

$0.51

Q2 FY2017+0.00%

Report Date

May 15, 2017

EPS Beat/Miss

—

Price Before

$0.41

Price After

$0.41

Q4 FY2016+0.00%

Report Date

Nov 15, 2016

EPS Beat/Miss

—

Price Before

$0.45

Price After

$0.45

Q3 FY2016+0.00%

Report Date

Aug 25, 2016

EPS Beat/Miss

—

Price Before

$0.55

Price After

$0.55

Q2 FY2016+0.00%

Report Date

Apr 12, 2016

EPS Beat/Miss

—

Price Before

$0.70

Price After

$0.70

Beat Rate0 / 8 quarters

Largest Move+0.00% (Q4 FY2018)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Medite Cancer Diagnostics, Inc. (MDIT) most recently reported earnings on November 14, 2018 for Q4 FY2018, posting EPS of $-0.01 (in line with the analyst consensus of —). The next MDIT earnings date is expected around September 1, 2026.

Each quarter, investors track MDIT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDIT revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

MDIT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

MDIT earnings · 4 questions

Medite Cancer Diagnostics, Inc.'s next earnings report is expected around September 1, 2026. MDIT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDIT historically reports after market close (AMC).

MDIT earnings datewhen is MDIT earningsMDIT next earnings datewhen does MDIT report earningsMDIT earnings calendar

▸ Source: FMP · Medite Cancer Diagnostics, Inc. SEC filings · US GAAP · Medite Cancer Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026